Unknown

Dataset Information

0

Pharmacokinetic-pharmacodynamic analyses for efficacy of ceftaroline fosamil in patients with community-acquired bacterial pneumonia.


ABSTRACT: Pharmacokinetic-pharmacodynamic (PK-PD) analyses for efficacy using phase III trial data from patients treated with a ceftaroline fosamil dosing regimen of 600 mg intravenously (i.v.) every 12 h (q12h) for 5 to 7 days for community-acquired bacterial pneumonia (CABP) were conducted. High clinical and microbiological success rates (84.7 and 86.3%, respectively) and percentages of time during the dosing interval that free-drug steady-state concentrations remained above the MIC (f%T>MIC) (98.4% had f%T>MIC values of ?63.3) were observed among 124 microbiologically evaluable patients. As a result, significant PK-PD relationships could not be identified. These data provide support for the use of a ceftaroline fosamil dosing regimen of 600 mg i.v. q12h to treat patients with CABP.

SUBMITTER: Bhavnani SM 

PROVIDER: S-EPMC3837912 | biostudies-literature | 2013 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pharmacokinetic-pharmacodynamic analyses for efficacy of ceftaroline fosamil in patients with community-acquired bacterial pneumonia.

Bhavnani Sujata M SM   Hammel Jeffrey P JP   Van Wart Scott A SA   Rubino Christopher M CM   Reynolds Daniel K DK   Forrest Alan A   Khariton Tatiana T   Friedland H David HD   Riccobene Todd A TA   Ambrose Paul G PG  

Antimicrobial agents and chemotherapy 20130916 12


Pharmacokinetic-pharmacodynamic (PK-PD) analyses for efficacy using phase III trial data from patients treated with a ceftaroline fosamil dosing regimen of 600 mg intravenously (i.v.) every 12 h (q12h) for 5 to 7 days for community-acquired bacterial pneumonia (CABP) were conducted. High clinical and microbiological success rates (84.7 and 86.3%, respectively) and percentages of time during the dosing interval that free-drug steady-state concentrations remained above the MIC (f%T>MIC) (98.4% had  ...[more]

Similar Datasets

| S-EPMC4291374 | biostudies-literature
| S-EPMC4269637 | biostudies-literature
| S-EPMC6522587 | biostudies-literature
| S-EPMC8563558 | biostudies-literature
| S-EPMC6449570 | biostudies-literature
| S-EPMC8048922 | biostudies-literature
| S-EPMC6535521 | biostudies-literature
| S-EPMC6199731 | biostudies-literature
| S-EPMC4356773 | biostudies-literature
| S-EPMC8841461 | biostudies-literature